Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine efficacy in chronic hepatitis B
IRCT138807112539N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in Chronic Hepatitis B (CHB), sponsored by Arak University of Medical Sciences. Started Jul 2009; status: completed.
02
Drugs
colchicine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on IRCT138807112539N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138807112539N1.